900 related articles for article (PubMed ID: 29892070)
21. SR18292 exerts potent antitumor effects in multiple myeloma via inhibition of oxidative phosphorylation.
Xiang Y; Fang B; Liu Y; Yan S; Cao D; Mei H; Wang Q; Hu Y; Guo T
Life Sci; 2020 Sep; 256():117971. PubMed ID: 32553925
[TBL] [Abstract][Full Text] [Related]
22. Targeting metabolic flexibility by simultaneously inhibiting respiratory complex I and lactate generation retards melanoma progression.
Chaube B; Malvi P; Singh SV; Mohammad N; Meena AS; Bhat MK
Oncotarget; 2015 Nov; 6(35):37281-99. PubMed ID: 26484566
[TBL] [Abstract][Full Text] [Related]
23. R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m
Qing Y; Dong L; Gao L; Li C; Li Y; Han L; Prince E; Tan B; Deng X; Wetzel C; Shen C; Gao M; Chen Z; Li W; Zhang B; Braas D; Ten Hoeve J; Sanchez GJ; Chen H; Chan LN; Chen CW; Ann D; Jiang L; Müschen M; Marcucci G; Plas DR; Li Z; Su R; Chen J
Mol Cell; 2021 Mar; 81(5):922-939.e9. PubMed ID: 33434505
[TBL] [Abstract][Full Text] [Related]
24. Enhanced Sensitivity of Nonsmall Cell Lung Cancer with Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors to Phenformin: The Roles of a Metabolic Shift to Oxidative Phosphorylation and Redox Balance.
Kim S; Im JH; Kim WK; Choi YJ; Lee JY; Kim SK; Kim SJ; Kwon SW; Kang KW
Oxid Med Cell Longev; 2021; 2021():5428364. PubMed ID: 34367462
[TBL] [Abstract][Full Text] [Related]
25. JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis.
Lynch JR; Salik B; Connerty P; Vick B; Leung H; Pijning A; Jeremias I; Spiekermann K; Trahair T; Liu T; Haber M; Norris MD; Woo AJ; Hogg P; Wang J; Wang JY
Leukemia; 2019 Jun; 33(6):1400-1410. PubMed ID: 30622285
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrial fission induces glycolytic reprogramming in cancer-associated myofibroblasts, driving stromal lactate production, and early tumor growth.
Guido C; Whitaker-Menezes D; Lin Z; Pestell RG; Howell A; Zimmers TA; Casimiro MC; Aquila S; Ando' S; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Oncotarget; 2012 Aug; 3(8):798-810. PubMed ID: 22878233
[TBL] [Abstract][Full Text] [Related]
27. Lactic acidosis switches cancer cells from aerobic glycolysis back to dominant oxidative phosphorylation.
Wu H; Ying M; Hu X
Oncotarget; 2016 Jun; 7(26):40621-40629. PubMed ID: 27259254
[TBL] [Abstract][Full Text] [Related]
28. Adaptation of leukemia cells to hypoxic condition through switching the energy metabolism or avoiding the oxidative stress.
Goto M; Miwa H; Suganuma K; Tsunekawa-Imai N; Shikami M; Mizutani M; Mizuno S; Hanamura I; Nitta M
BMC Cancer; 2014 Feb; 14():76. PubMed ID: 24506813
[TBL] [Abstract][Full Text] [Related]
29. Targeting Oxidative Phosphorylation Reverses Drug Resistance in Cancer Cells by Blocking Autophagy Recycling.
Lee JS; Lee H; Jang H; Woo SM; Park JB; Lee SH; Kang JH; Kim HY; Song J; Kim SY
Cells; 2020 Sep; 9(9):. PubMed ID: 32883024
[TBL] [Abstract][Full Text] [Related]
30. Drugging OXPHOS Dependency in Cancer.
Cancer Discov; 2019 Aug; 9(8):OF10. PubMed ID: 31186236
[TBL] [Abstract][Full Text] [Related]
31. Including the mitochondrial metabolism of L-lactate in cancer metabolic reprogramming.
de Bari L; Atlante A
Cell Mol Life Sci; 2018 Aug; 75(15):2763-2776. PubMed ID: 29728715
[TBL] [Abstract][Full Text] [Related]
32. Multiple blocks in the engagement of oxidative phosphorylation in putative ovarian cancer stem cells: implication for maintenance therapy with glycolysis inhibitors.
Alvero AB; Montagna MK; Sumi NJ; Joo WD; Graham E; Mor G
Oncotarget; 2014 Sep; 5(18):8703-15. PubMed ID: 25237928
[TBL] [Abstract][Full Text] [Related]
33. Intrinsic OXPHOS limitations underlie cellular bioenergetics in leukemia.
Nelson MA; McLaughlin KL; Hagen JT; Coalson HS; Schmidt C; Kassai M; Kew KA; McClung JM; Neufer PD; Brophy P; Vohra NA; Liles D; Cabot MC; Fisher-Wellman KH
Elife; 2021 Jun; 10():. PubMed ID: 34132194
[TBL] [Abstract][Full Text] [Related]
34. BPR1J373, an Oral Multiple Tyrosine Kinase Inhibitor, Targets c-KIT for the Treatment of c-KIT-Driven Myeloid Leukemia.
Chen LT; Chen CT; Jiaang WT; Chen TY; Butterfield JH; Shih NY; Hsu JT; Lin HY; Lin SF; Tsai HJ
Mol Cancer Ther; 2016 Oct; 15(10):2323-2333. PubMed ID: 27512117
[TBL] [Abstract][Full Text] [Related]
35. Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity.
Chen D; Barsoumian HB; Fischer G; Yang L; Verma V; Younes AI; Hu Y; Masropour F; Klein K; Vellano C; Marszalek J; Davies M; Cortez MA; Welsh J
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581056
[TBL] [Abstract][Full Text] [Related]
36. IACS-010759, a potent inhibitor of glycolysis-deficient hypoxic tumor cells, inhibits mitochondrial respiratory complex I through a unique mechanism.
Tsuji A; Akao T; Masuya T; Murai M; Miyoshi H
J Biol Chem; 2020 May; 295(21):7481-7491. PubMed ID: 32295842
[TBL] [Abstract][Full Text] [Related]
37. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.
Lu J; Tan M; Cai Q
Cancer Lett; 2015 Jan; 356(2 Pt A):156-64. PubMed ID: 24732809
[TBL] [Abstract][Full Text] [Related]
38. A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in Melanoma.
Vashisht Gopal YN; Gammon S; Prasad R; Knighton B; Pisaneschi F; Roszik J; Feng N; Johnson S; Pramanik S; Sudderth J; Sui D; Hudgens C; Fischer GM; Deng W; Reuben A; Peng W; Wang J; McQuade JL; Tetzlaff MT; Di Francesco ME; Marszalek J; Piwnica-Worms D; DeBerardinis RJ; Davies MA
Clin Cancer Res; 2019 Nov; 25(21):6429-6442. PubMed ID: 31439581
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma.
Raggi C; Taddei ML; Sacco E; Navari N; Correnti M; Piombanti B; Pastore M; Campani C; Pranzini E; Iorio J; Lori G; Lottini T; Peano C; Cibella J; Lewinska M; Andersen JB; di Tommaso L; Viganò L; Di Maira G; Madiai S; Ramazzotti M; Orlandi I; Arcangeli A; Chiarugi P; Marra F
J Hepatol; 2021 Jun; 74(6):1373-1385. PubMed ID: 33484774
[TBL] [Abstract][Full Text] [Related]
40. Matrine induces apoptosis in human acute myeloid leukemia cells via the mitochondrial pathway and Akt inactivation.
Zhang S; Zhang Y; Zhuang Y; Wang J; Ye J; Zhang S; Wu J; Yu K; Han Y
PLoS One; 2012; 7(10):e46853. PubMed ID: 23056487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]